-
1
-
-
21044443182
-
Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
-
DOI 10.2174/1381612054367300
-
Yamagishi S, Imaizumi T. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des: 2005; 11 2279 2299 (Pubitemid 40872698)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.18
, pp. 2279-2299
-
-
Yamagishi, S.-I.1
Imaizumi, T.2
-
2
-
-
33645890286
-
Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes
-
Takenaka K, Yamagishi S, Matsui T, Nakamura K, Imaizumi T. Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr Neurovasc Res: 2006; 3 73 77
-
(2006)
Curr Neurovasc Res
, vol.3
, pp. 73-77
-
-
Takenaka, K.1
Yamagishi, S.2
Matsui, T.3
Nakamura, K.4
Imaizumi, T.5
-
3
-
-
35348927441
-
Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation and products (sRAGE) in diabetes
-
DOI 10.2174/138945007782151298
-
Yamagishi S, Matsui T, Nakamura K. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes. Curr Drug Targets: 2007; 8 1138 1143 (Pubitemid 47578142)
-
(2007)
Current Drug Targets
, vol.8
, Issue.10
, pp. 1138-1143
-
-
Yamagishi, S.-I.1
Matsui, T.2
Nakamura, K.3
-
4
-
-
58149090676
-
The role of incretins in glucose homeostasis and diabetes treatment
-
Kim W, Egan J M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev: 2008; 60 470 512
-
(2008)
Pharmacol Rev
, vol.60
, pp. 470-512
-
-
Kim, W.1
Egan, J.M.2
-
5
-
-
36148996843
-
G-protein-coupled receptors and islet function-Implications for treatment of type 2 diabetes
-
DOI 10.1016/j.pharmthera.2007.08.002, PII S0163725807001593
-
Winzell M S, Ahrén B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Rev: 2007; 116 437 448 (Pubitemid 350116941)
-
(2007)
Pharmacology and Therapeutics
, vol.116
, Issue.3
, pp. 437-448
-
-
Winzell, M.S.1
Ahren, B.2
-
6
-
-
0022385480
-
Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content
-
DOI 10.1007/BF00291078
-
Siegel E G, Creutzfeldt W. Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content. Diabetologia: 1985; 28 857 861 (Pubitemid 16176057)
-
(1985)
Diabetologia
, vol.28
, Issue.11
, pp. 857-861
-
-
Siegel, E.G.1
Creutzfeldt, W.2
-
7
-
-
0027136670
-
Gastric inhibitory polypeptide receptor, a member of the secretin- vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain
-
DOI 10.1210/en.133.6.2861
-
Usdin T B, Mezey E, Button D C, Brownstein M J, Bonner T I. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology: 1993; 133 2861 2870 (Pubitemid 24000747)
-
(1993)
Endocrinology
, vol.133
, Issue.6
, pp. 2861-2870
-
-
Usdin, T.B.1
Mezey, E.2
Button, D.C.3
Brownstein, M.J.4
Bonner, T.I.5
-
8
-
-
33750913676
-
Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation
-
DOI 10.1007/s00125-006-0437-7
-
Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M. Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation. Diabetologia: 2006; 49 3094 3099 (Pubitemid 44730314)
-
(2006)
Diabetologia
, vol.49
, Issue.12
, pp. 3094-3099
-
-
Yoshida, T.1
Yamagishi, S.2
Nakamura, K.3
Matsui, T.4
Imaizumi, T.5
Takeuchi, M.6
Koga, H.7
Ueno, T.8
Sata, M.9
-
9
-
-
33746019939
-
Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression
-
DOI 10.1074/jbc.M602110200
-
Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem: 2006; 281 20213 20220 (Pubitemid 44065796)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.29
, pp. 20213-20220
-
-
Yamagishi, S.-I.1
Nakamura, K.2
Matsui, T.3
Inagaki, Y.4
Takenaka, K.5
Jinnouchi, Y.6
Yoshida, Y.7
Matsuura, T.8
Narama, I.9
Motomiya, Y.10
Takeuchi, M.11
Inoue, H.12
Yoshimura, A.13
Bucala, R.14
Imaizumi, T.15
-
10
-
-
0028843677
-
Tumour necrosis factor alpha-induced oxidative burst in neutrophils adherent to fibronectin: Effects of cyclic AMP-elevating agents
-
Ottonello L, Morone M P, Dapino P, Dallegri F. Tumour necrosis factor alpha-induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP-elevating agents. Br J Haematol: 1995; 91 566 570
-
(1995)
Br J Haematol
, vol.91
, pp. 566-570
-
-
Ottonello, L.1
Morone, M.P.2
Dapino, P.3
Dallegri, F.4
-
11
-
-
0034682796
-
The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells
-
Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem: 2000; 275 25781 25790
-
(2000)
J Biol Chem
, vol.275
, pp. 25781-25790
-
-
Tanaka, N.1
Yonekura, H.2
Yamagishi, S.3
Fujimori, H.4
Yamamoto, Y.5
Yamamoto, H.6
-
12
-
-
34248146103
-
Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats
-
DOI 10.1159/000099244
-
Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res: 2007; 39 92 97 (Pubitemid 46909866)
-
(2007)
Ophthalmic Research
, vol.39
, Issue.2
, pp. 92-97
-
-
Yamagishi, S.-I.1
Matsui, T.2
Nakamura, K.3
Yoshida, T.4
Takeuchi, M.5
Inoue, H.6
Yoshida, Y.7
Imaizumi, T.8
-
13
-
-
0031773362
-
Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells
-
DOI 10.1007/s001250051089
-
Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia: 1998; 41 1435 1441 (Pubitemid 28551614)
-
(1998)
Diabetologia
, vol.41
, Issue.12
, pp. 1435-1441
-
-
Yamagishi, S.1
Fujimori, H.2
Yonekura, H.3
Yamamoto, Y.4
Yamamoto, H.5
-
14
-
-
73949118948
-
Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
-
Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression. Biophys Res Commun: 2010; 391 1405 1408
-
(2010)
Biophys Res Commun
, vol.391
, pp. 1405-1408
-
-
Ishibashi, Y.1
Matsui, T.2
Takeuchi, M.3
Yamagishi, S.4
-
15
-
-
33947354929
-
Vascular cell adhesion molecule-1: A viable therapeutic target for atherosclerosis?
-
DOI 10.1111/j.1742-1241.2007.01330.x
-
Preiss D J, Sattar N. Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? Int J Clin Pract: 2007; 6 697 701 (Pubitemid 46449832)
-
(2007)
International Journal of Clinical Practice
, vol.61
, Issue.4
, pp. 697-701
-
-
Preiss, D.J.1
Sattar, N.2
-
16
-
-
35348837775
-
Plasminogen activator inhibitor-1 in vascular thrombosis
-
Westrick R J, Eitzman D T. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets: 2007; 8 966 1002
-
(2007)
Curr Drug Targets
, vol.8
, pp. 966-1002
-
-
Westrick, R.J.1
Eitzman, D.T.2
-
17
-
-
80054110585
-
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein e knockout mice
-
Nagashima M, Watanabe T, Terasaki M, Tomoyasu M, Nohtomi K, Kim-Kaneyama J, Miyazaki A, Hirano T. Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia: 2011; 54 2649 2659
-
(2011)
Diabetologia
, vol.54
, pp. 2649-2659
-
-
Nagashima, M.1
Watanabe, T.2
Terasaki, M.3
Tomoyasu, M.4
Nohtomi, K.5
Kim-Kaneyama, J.6
Miyazaki, A.7
Hirano, T.8
-
18
-
-
33749871472
-
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes
-
DOI 10.1210/jc.2006-1009
-
Herman G A, Bergman A, Stevens C, Kotey P, Yi B, Zhao P, Dietrich B, Golor G, Schrodter A, Keymeulen B, Lasseter K C, Kipnes M S, Snyder K, Hilliard D, Tanen M, Cilissen C, De Smet M, de Lepeleire I, Van Dyck K, Wang A Q, Zeng W, Davies M J, Tanaka W, Holst J J, Deacon C F, Gottesdiener K M, Wagner J A. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab: 2006; 91 4612 4619 (Pubitemid 44833446)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.11
, pp. 4612-4619
-
-
Herman, G.A.1
Bergman, A.2
Stevens, C.3
Kotey, P.4
Yi, B.5
Zhao, P.6
Dietrich, B.7
Golor, G.8
Schrodter, A.9
Keymeulen, B.10
Lasseter, K.C.11
Kipnes, M.S.12
Snyder, K.13
Hilliard, D.14
Tanen, M.15
Cilissen, C.16
De Smet, M.17
De Lepeleire, I.18
Van Dyck, K.19
Wang, A.Q.20
Zeng, W.21
Davies, M.J.22
Tanaka, W.23
Holst, J.J.24
Deacon, C.F.25
Gottesdiener, K.M.26
Wagner, J.A.27
more..
-
19
-
-
0034136370
-
Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo
-
Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med: 2000; 6 114 125
-
(2000)
Mol Med
, vol.6
, pp. 114-125
-
-
Takeuchi, M.1
Makita, Z.2
Bucala, R.3
Suzuki, T.4
Koike, T.5
Kameda, Y.6
|